Multiple Sclerosis - Cleveland Clinic

March 11, 2022/Neurosciences/Multiple Sclerosis

Multiple Sclerosis and Cannabis Use: Where Do Patients Get Their Information?

Survey suggests need for evidence-based education among patients and providers alike

22-NEU-2651159_Epstein-Barr-virus_650x450

February 7, 2022/Neurosciences/Multiple Sclerosis

Epstein-Barr Virus and Development of MS: Required, but Not Sufficient

Be careful not to overinterpret a recent important study

21-NEU-2526665_T-cell-activation_650x450

December 21, 2021/Neurosciences/Multiple Sclerosis

Antibody-Mediated Autoimmune Encephalitis: A Practical Approach to Diagnosis and Management

Objective clinical and radiographic findings are central to optimal outcomes

21-NEU-2489213-breakhrough-infection-650×450

November 12, 2021/COVID-19

Breakthrough COVID-19 in Patients With Multiple Sclerosis: Snapshot From One Data Registry

Unlikely to be severe, infections are associated with anti-CD20 therapies and fingolimod

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

21-NEU-2477458_teleneurology-cartoon_650x450

November 2, 2021/Health Information Technology

Virtual Visits Match In-Person Visits for Multiple Sclerosis Care, Longitudinal Study Shows

Findings support a role for teleneurology in MS management

21-NEU-2474109_mesenchymal-stem-cells_650x450

October 15, 2021/Neurosciences/Multiple Sclerosis

Intrathecally Delivered Enhanced Stem Cells Show Promise in Progressive MS

Phase 2 clinical study supports safety and efficacy of MSC-NTFs

21-NEU-2259158 MS-in-Black-Americans_650x450

August 9, 2021/Neurosciences/Multiple Sclerosis

Black Americans Suffer Greater Multiple Sclerosis Disease Burden Than Whites

Database study reveals racial differences across clinical and imaging domains

July 8, 2021/Basic & Translational Science

How Well Do Current MRI Modalities Measure Cortical Lesion Load in Multiple Sclerosis?

Shortcomings in specificity show influence of cortical changes beyond demyelination

July 1, 2021/Neurosciences/Multiple Sclerosis

Deep Gray Matter Injury in Multiple Sclerosis: What We Know, Why It Matters

A new NAIMS consensus statement summarizes evidence, guides MRI investigation

21-NEU-2079842_COVID-19-in-MS-patients_650x450

March 29, 2021/COVID-19

Registry Study Pinpoints Risk Factors for Worse COVID-19 Outcomes in Patients With MS

Ambulation disability carries greatest risk, most disease-modifying therapies aren’t implicated